ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC Pharmaceuticals (Nasdaq: ORIC), a clinical stage oncology company, has announced its participation in three major investor conferences in February 2025. The company will engage in fireside chats at the following events:
- Jones Research Precision Medicine Day on February 3 at 12:30 p.m. ET
- Guggenheim Securities SMID Cap Biotech Conference on February 5 at 1:30 p.m. ET
- Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11 at 12:00 p.m. ET
Live webcasts of these discussions will be accessible through the investor section of ORIC's website at www.oricpharma.com, with replays available for 90 days after each event.
ORIC Pharmaceuticals (Nasdaq: ORIC), un'azienda oncológica in fase clinica, ha annunciato la sua partecipazione a tre importanti conferenze per investitori nel febbraio 2025. L'azienda parteciperà a conversazioni informali nei seguenti eventi:
- Giornata della Medicina di Precisione di Jones Research il 3 febbraio alle 12:30 ET
- Conferenza Biotech per SMID Cap di Guggenheim Securities il 5 febbraio alle 13:30 ET
- 35° Conferenza Annuale su Salute e Scienze della Vita di Oppenheimer l'11 febbraio alle 12:00 ET
Le webcasting in diretta di queste discussioni saranno accessibili attraverso la sezione investitori del sito web di ORIC all'indirizzo www.oricpharma.com, con repliche disponibili per 90 giorni dopo ogni evento.
ORIC Pharmaceuticals (Nasdaq: ORIC), una empresa oncológica en etapa clínica, ha anunciado su participación en tres importantes conferencias para inversores en febrero de 2025. La empresa participará en charlas informales en los siguientes eventos:
- Día de Medicina de Precisión de Jones Research el 3 de febrero a las 12:30 p.m. ET
- Conferencia Biotech de SMID Cap de Guggenheim Securities el 5 de febrero a la 1:30 p.m. ET
- 35ª Conferencia Anual de Salud y Ciencias de la Vida de Oppenheimer el 11 de febrero a las 12:00 p.m. ET
Las transmisiones en vivo de estas discusiones estarán disponibles a través de la sección para inversores del sitio web de ORIC en www.oricpharma.com, con repeticiones disponibles durante 90 días después de cada evento.
ORIC 제약 (Nasdaq: ORIC)은 임상 단계의 종양학 회사로, 2025년 2월에 열리는 세 가지 주요 투자자 회의에 참여할 것이라고 발표했습니다. 회사는 다음 이벤트에서 대화형 좌담회에 참여할 것입니다:
- 존스 리서치 정밀 의학의 날 2월 3일 오후 12:30 ET
- 구겐하임 증권 SMID 캡 바이오텍 회의 2월 5일 오후 1:30 ET
- 오펜하이머 제35회 연례 의료 생명 과학 회의 2월 11일 오후 12:00 ET
이 논의의 라이브 웹캐스트는 ORIC의 웹사이트의 투자자 섹션을 통해 접속할 수 있으며, 각 행사 후 90일 동안 다시 보기 가능하니다.
ORIC Pharmaceuticals (Nasdaq: ORIC), une entreprise de cancérologie en phase clinique, a annoncé sa participation à trois grandes conférences pour investisseurs en février 2025. L'entreprise participera à des conversations informelles lors des événements suivants :
- Journée de la Médecine de Précision de Jones Research le 3 février à 12h30 ET
- Conférence Biotech SMID Cap de Guggenheim Securities le 5 février à 13h30 ET
- 35ème Conférence Annuelle sur la Santé et les Sciences de la Vie d'Oppenheimer le 11 février à 12h00 ET
Les webcasts en direct de ces discussions seront accessibles via la section investisseurs du site web d'ORIC à l'adresse www.oricpharma.com, avec des rediffusions disponibles pendant 90 jours après chaque événement.
ORIC Pharmaceuticals (Nasdaq: ORIC), ein Unternehmen in der klinischen Phase der Onkologie, hat seine Teilnahme an drei wichtigen Investorenkonferenzen im Februar 2025 bekannt gegeben. Das Unternehmen wird an den folgenden Veranstaltungen Vorstandsgespräche führen:
- Jones Research Precision Medicine Day am 3. Februar um 12:30 Uhr ET
- Guggenheim Securities SMID Cap Biotech Conference am 5. Februar um 13:30 Uhr ET
- 35. Jahrestagung für Gesundheitswesen und Lebenswissenschaften von Oppenheimer am 11. Februar um 12:00 Uhr ET
Live-Webcasts dieser Diskussionen sind über den Investorenbereich der ORIC-Website unter www.oricpharma.com zugänglich, mit Wiederholungen, die 90 Tage nach jeder Veranstaltung verfügbar sind.
- None.
- None.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in February:
- Jones Research Precision Medicine Day – Participating in a fireside chat on Monday, February 3, 2025, at 12:30 p.m. ET
- Guggenheim Securities SMID Cap Biotech Conference – Participating in a fireside chat on Wednesday, February 5, 2025, at 1:30 p.m. ET
- Oppenheimer 35th Annual Healthcare Life Sciences Conference – Participating in a fireside chat on Tuesday, February 11, 2025, at 12:00 p.m. ET
Live webcasts of the discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers, and (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
Contact:
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com
FAQ
What investor conferences will ORIC Pharmaceuticals attend in February 2025?
How can investors access ORIC Pharmaceuticals' conference presentations in February 2025?
What time is ORIC's presentation at the Oppenheimer Healthcare Conference on February 11, 2025?
How long will the replays of ORIC's February 2025 conference presentations be available?
